JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SAFE
3151
Safehold
SAFE
$865M
| $2.37M | ﹤0.01% |
45,047
-26,686
| -37% | -$1.37M |
2017 Q4
2 quarters
|
|
3152
ANI Pharmaceuticals
ANIP
$1.65B
| $2.37M | ﹤0.01% |
35,399
+4,938
| +16% | +$308K |
2016 Q1
9 quarters
|
|
3153
Fidelity Total Bond ETF
FBND
$27.9B
| $2.36M | ﹤0.01% |
48,324
+260
| +0.5% | +$12.7K |
2015 Q3
11 quarters
|
|
3154
CALL
Hartford Financial Services
HIG
$33.9B
| $2.36M | ﹤0.01% |
+46,200
| New | +$2.42M |
2018 Q2
0 quarters
|
|
|
GOGL
3155
DELISTED
Golden Ocean Group
GOGL
| $2.36M | ﹤0.01% |
+271,721
| New | +$2.28M |
2018 Q2
0 quarters
|
|
|
BMTC
3156
DELISTED
Bryn Mawr Bank Corp
BMTC
| $2.35M | ﹤0.01% |
50,770
+1,242
| +3% | +$57.4K |
2016 Q2
8 quarters
|
|
|
NXGN
3157
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.35M | ﹤0.01% |
120,281
+48,941
| +69% | +$774K |
2016 Q4
6 quarters
|
|
|
NTUS
3158
DELISTED
Natus Medical Inc
NTUS
| $2.34M | ﹤0.01% |
67,835
-158,044
| -70% | -$5.54M |
2013 Q2
20 quarters
|
|
|
RFP
3159
DELISTED
Resolute Forest Products Inc.
RFP
| $2.34M | ﹤0.01% |
225,913
+158,012
| +233% | +$1.59M |
2013 Q2
20 quarters
|
|
|
ALX
3160
Alexander's
ALX
$1.24B
| $2.34M | ﹤0.01% |
6,105
+5,371
| +732% | +$2.08M |
2015 Q3
11 quarters
|
|
3161
iShares US Medical Devices ETF
IHI
$3.46B
| $2.33M | ﹤0.01% |
69,720
-292,890
| -81% | -$9.54M |
2015 Q4
10 quarters
|
|
|
VNET
3162
VNET Group
VNET
$1.48B
| $2.33M | ﹤0.01% |
239,842
+168,942
| +238% | +$1.2M |
2015 Q2
12 quarters
|
|
3163
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$7.74B
| $2.31M | ﹤0.01% |
125,169
+4,691
| +4% | +$86.3K |
2016 Q2
8 quarters
|
|
3164
PUT
Teva Pharmaceutical Industries Limited
TEVA
$45.8B
| $2.31M | ﹤0.01% |
95,000
-100,700
| -51% | -$2.05M |
2016 Q4
6 quarters
|
|
3165
Utah Medical Products
UTMD
$236M
| $2.31M | ﹤0.01% |
20,950
-6,303
| -23% | -$658K |
2015 Q3
11 quarters
|
|
3166
CALL
Ultragenyx Pharmaceutical
RARE
$1.49B
| $2.31M | ﹤0.01% |
+30,000
| New | +$1.94M |
2018 Q2
0 quarters
|
|
|
3167
PUT
Ultragenyx Pharmaceutical
RARE
$1.49B
| $2.31M | ﹤0.01% |
+30,000
| New | +$1.94M |
2018 Q2
0 quarters
|
|
|
CZR
3168
CALL
DELISTED
Caesars Entertainment Corporation
CZR
| $2.3M | ﹤0.01% |
+215,000
| New | +$2.51M |
2018 Q2
0 quarters
|
|
|
CWBC
3169
Community West Bancshares
CWBC
$717M
| $2.3M | ﹤0.01% |
108,529
+1,760
| +2% | +$36.9K |
2016 Q2
8 quarters
|
|
3170
Sierra Bancorp
BSRR
$513M
| $2.29M | ﹤0.01% |
81,207
-15,423
| -16% | -$435K |
2013 Q2
20 quarters
|
|
|
FARO
3171
DELISTED
Faro Technologies
FARO
| $2.29M | ﹤0.01% |
42,107
+18,808
| +81% | +$1.05M |
2016 Q1
9 quarters
|
|
3172
Viridian Therapeutics
VRDN
$2.2B
| $2.28M | ﹤0.01% |
23,721
+1,881
| +9% | +$199K |
2017 Q3
3 quarters
|
|
3173
Marten Transport
MRTN
$1.09B
| $2.28M | ﹤0.01% |
145,838
+78,810
| +118% | +$1.16M |
2015 Q4
10 quarters
|
|
3174
Viasat
VSAT
$9.96B
| $2.28M | ﹤0.01% |
34,661
+2,203
| +7% | +$141K |
2016 Q4
6 quarters
|
|
|
QIWI
3175
DELISTED
QIWI PLC
QIWI
| $2.28M | ﹤0.01% |
144,556
+741
| +0.5% | +$12.7K |
2014 Q1
17 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.